Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 208

1.

Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy.

Narváez J, Juarez-López P, LLuch J, Narváez JA, Palmero R, García Del Muro X, Nolla JM, Domingo-Domenech E.

Autoimmun Rev. 2018 Oct;17(10):1040-1045. doi: 10.1016/j.autrev.2018.05.002. Epub 2018 Aug 10. Review.

PMID:
30103042
2.

Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study.

Labad J, Rozadilla A, Garcia-Sancho P, Nolla JM, Montanya E.

Int J Endocrinol. 2018 May 2;2018:1897058. doi: 10.1155/2018/1897058. eCollection 2018.

3.

Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus.

Julià A, López-Longo FJ, Pérez Venegas JJ, Bonàs-Guarch S, Olivé À, Andreu JL, Aguirre-Zamorano MÁ, Vela P, Nolla JM, de la Fuente JLM, Zea A, Pego-Reigosa JM, Freire M, Díez E, Rodríguez-Almaraz E, Carreira P, Blanco R, Taboada VM, López-Lasanta M, Corbeto ML, Mercader JM, Torrents D, Absher D, Marsal S, Fernández-Nebro A.

Arthritis Res Ther. 2018 May 30;20(1):100. doi: 10.1186/s13075-018-1604-1.

4.

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.

Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, Gallego R, Salom D, Ortego N, García-Serrano JL, Callejas-Rubio JL, Herreras JM, García-Aparicio Á, Maíz O, Blanco A, Torre I, Díaz-Valle D, Pato E, Aurrecoechea E, Caracuel MA, Gamero F, Minguez E, Carrasco-Cubero C, Olive A, Vázquez J, Ruiz-Moreno O, Manero J, Muñoz-Fernández S, Martinez MG, Rubio-Romero E, Toyos-Sáenz de Miera FJ, López Longo FJ, Nolla JM, Revenga M, González-Vela C, Loricera J, Atienza-Mateo B, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.

Ophthalmology. 2018 Sep;125(9):1444-1451. doi: 10.1016/j.ophtha.2018.02.020. Epub 2018 Mar 27.

PMID:
29602570
5.

Spanish consensus on treat to target for osteoporosis.

Nogués X, Nolla JM, Casado E, Jódar E, Muñoz-Torres M, Quesada-Gómez JM, Canals L, Balcells M, Lizán L.

Osteoporos Int. 2018 Feb;29(2):489-499. doi: 10.1007/s00198-017-4310-y. Epub 2017 Nov 24.

6.

Prevalence of Nasal Colonization with Staphylococcus aureus in Patients with Rheumatoid Arthritis.

Albert G, Ricse M, Narvaez J, Rodriguez-Moreno J, Nolla JM, Dominguez-Luzon M, Gomez-Vaquero C.

Curr Rheumatol Rev. 2018 Apr 20;14(1):78-83. doi: 10.2174/1573397113666171020102300.

PMID:
29057725
7.

Severe vitamin D deficiency upon admission in critically ill patients is related to acute kidney injury and a poor prognosis.

Zapatero A, Dot I, Diaz Y, Gracia MP, Pérez-Terán P, Climent C, Masclans JR, Nolla J.

Med Intensiva. 2018 May;42(4):216-224. doi: 10.1016/j.medin.2017.07.004. Epub 2017 Aug 26. English, Spanish.

8.

High Prevalence of Gallstone Disease in Rheumatoid Arthritis: A New Comorbidity Related to Dyslipidemia?

García-Gómez MC, de Lama E, Ordoñez-Palau S, Nolla JM, Corbella E, Pintó X.

Reumatol Clin. 2017 Aug 1. pii: S1699-258X(17)30172-9. doi: 10.1016/j.reuma.2017.06.013. [Epub ahead of print] English, Spanish.

9.

Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study.

Balsa A, Lojo-Oliveira L, Alperi-López M, García-Manrique M, Ordóñez-Cañizares C, Pérez L, Ruiz-Esquide V, Corrales A, Narváez J, Rey-Rey J, Rodríguez-Lozano C, Ojeda S, Muñoz-Fernández S, Nolla JM, García-Torrón J, Gamero F, García-Vicuña R, Hernández-Cruz B, Campos J, Rosas J, García-Llorente JF, Gómez-Centeno A, Cáliz R, Sanmartí R, Bermúdez A, Abasolo-Alcázar L, Fernández-Nebro A, Rodríguez-Rodríguez L, Marras C, González-Gay MÁ, Hmamouchi I, Martín-Mola E.

Reumatol Clin. 2017 Jul 12. pii: S1699-258X(17)30134-1. doi: 10.1016/j.reuma.2017.06.002. [Epub ahead of print] English, Spanish.

10.

Erratum to "The activity of a Spanish bone densitometry unit revisited under the point of view of FRAX" <[Reumatol Clin 8 (2012) 179-183]>.

Gómez-Vaquero C, Bianchi M, Santo P, Roig-Vilaseca D, Narváez J, Nolla JM.

Reumatol Clin. 2017 Jul - Aug;13(4):248. doi: 10.1016/j.reuma.2017.06.001. English, Spanish. No abstract available.

11.

Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus.

Aterido A, Julià A, Carreira P, Blanco R, López-Longo JJ, Venegas JJP, Olivé À, Andreu JL, Aguirre-Zamorano MÁ, Vela P, Nolla JM, Marenco-de la Fuente JL, Zea A, Pego JM, Freire M, Díez E, López-Lasanta M, López-Corbeto M, Palau N, Tortosa R, Gelpí JL, Absher D, Myers RM, Fernández-Nebro A, Marsal S.

Arthritis Res Ther. 2017 Jun 15;19(1):138. doi: 10.1186/s13075-017-1345-6.

12.

The value of repeat biopsy in lupus nephritis flares.

Narváez J, Ricse M, Gomà M, Mitjavila F, Fulladosa X, Capdevila O, Torras J, Juanola X, Pujol-Farriols R, Nolla JM.

Medicine (Baltimore). 2017 Jun;96(24):e7099. doi: 10.1097/MD.0000000000007099. Review.

13.

An estimate of the cost of administering intravenous biological agents in Spanish day hospitals.

Nolla JM, Martín E, Llamas P, Manero J, Rodríguez de la Serna A, Fernández-Miera MF, Rodríguez M, López JM, Ivanova A, Aragón B.

Ther Clin Risk Manag. 2017 Mar 14;13:325-334. doi: 10.2147/TCRM.S112062. eCollection 2017.

14.

Adult-onset Still's disease with atypical cutaneous manifestations.

Narváez Garcia FJ, Pascual M, López de Recalde M, Juarez P, Morales-Ivorra I, Notario J, Jucglà A, Nolla JM.

Medicine (Baltimore). 2017 Mar;96(11):e6318. doi: 10.1097/MD.0000000000006318.

15.

Recommendations for the use of parenteral methotrexate in rheumatic diseases.

Tornero Molina J, Calvo Alen J, Ballina J, Belmonte MÁ, Blanco FJ, Caracuel MÁ, Carbonell J, Corominas H, Chamizo E, Hidalgo C, Ivorra JR, Marenco JL, Moreno Muelas JV, Muñoz-Fernández S, Nolla JM, Pérez T, Sanmarti R, Trenor P, Urrego C, Vidal J, Rosas Gomez de Salazar J.

Reumatol Clin. 2018 May - Jun;14(3):142-149. doi: 10.1016/j.reuma.2016.12.001. Epub 2017 Jan 9. English, Spanish.

16.

Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature.

Narváez J, García-Gómez C, Álvarez L, Santo P, Aparicio M, Pascual M, López de Recalde M, Borrell H, Nolla JM.

Medicine (Baltimore). 2016 Nov;95(48):e5511. Review.

17.

Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature.

Borrell H, Narváez J, Alegre JJ, Castellví I, Mitjavila F, Aparicio M, Armengol E, Molina-Molina M, Nolla JM.

Medicine (Baltimore). 2016 Aug;95(33):e4626. doi: 10.1097/MD.0000000000004626. Review.

18.

Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain.

Nolla JM, Rodríguez M, Martin-Mola E, Raya E, Ibero I, Nocea G, Aragon B, Lizán L, Prades M.

Patient Prefer Adherence. 2016 Jun 20;10:1101-13. doi: 10.2147/PPA.S106311. eCollection 2016.

19.

Pyogenic arthritis of native joints due to Bacteroides fragilis: Case report and review of the literature.

Nolla JM, Murillo O, Narvaez J, Vaquero CG, Lora-Tamayo J, Pedrero S, Cabo J, Ariza J.

Medicine (Baltimore). 2016 Jun;95(25):e3962. doi: 10.1097/MD.0000000000003962. Review.

20.

[Assessment of an intervention on cardiovascular risk factors in patients with rheumatoid arthritis].

Zacarías A, Narváez J, Rodríguez Moreno J, Jordana M, Nolla JM, Gómez Vaquero C.

Med Clin (Barc). 2016 Aug 5;147(3):109-12. doi: 10.1016/j.medcli.2016.03.020. Epub 2016 Apr 30. Spanish.

PMID:
27143527

Supplemental Content

Support Center